Merck has announced a €62m investment in its life science business, with the construction of a new quality control building at its Darmstadt headquarters. The 10,000sqm facility is part of a larger €1.5bn investment program at the site and will be built to meet the German Sustainable Building Council GOLD standard.
Robert Nass, Head of Quality & Regulatory Management for Merck’s Life Science business, emphasized the importance of the new quality control facility in delivering safe and high-quality products. The facility will play a key role in testing products for purity and detecting any harmful substances, with over 25 specialized labs within the Life Science business. Darmstadt serves as a vital research and development center for Merck’s life science technologies.
In addition to this investment, Merck recently expanded its Life Science distribution center in Schnelldorf with an €180m investment. The site has nearly doubled in size to 25,000 sqm and now includes a new manual down filling operation and additional space for global distribution of products to laboratories and research facilities.
Merck’s life science business operates in more than 50 production and testing sites, 64 distribution centers, and employs over 27,000 staff in 65 countries. The company continues to invest heavily in its life sciences division, underscoring its commitment to delivering innovative solutions that improve people’s lives. For more information on medical and life sciences, check out the July issue of gasworld global.
